Thus, it is likely that CDK12/13 coordinate translation initiation by directly or indirectly catalysing phosphorylation of multiple components of the translational machinery and controlling the expression of pro-tumoral players, like MYC or MCL-1, that are essential for tumour progression and acquisition of chemoresistance by cancer cells. The gene discussed is MYC; the disease is neoplasm.